Phase 1 study of autologous T cells bearing fully human chimeric antigen receptors targeting mesothelin in mesothelin-expressing cancers
Julie S. Barber-Rotenberg, Andrew R. Haas, Charu Aggarwal, Mark H. O'Hara et autres
2 citationsMolecular Therapy